Figure 3.

CTLA4–Ig (cytotoxic T lymphocyte-associated antigen 4–immunoglobulin fusion protein) blocks the T cell–antigen presenting cell (APC) interaction by binding to both CD80 and CD86, thus preventing CD28 interaction. CTLA4 has a higher affinity for the B7 molecules than does CD28. TCR, T cell receptor.

Malmström et al. Arthritis Research & Therapy 2005 7(Suppl 2):S15   doi:10.1186/ar1505